- Home
- SES vs CBLL Comparison
SES vs CBLL Comparison
Compare SES & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SES | CBLL |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | 280 |
| Industry | Auto Parts:O.E.M. | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 719.2M | 750.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SES | CBLL |
|---|---|---|
| Price | $1.13 | $18.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $4.00 | ★ $24.67 |
| AVG Volume (30 Days) | ★ 8.8M | 300.8K |
| Earning Date | 03-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $148.49 | $29.57 |
| Revenue Next Year | $170.97 | $28.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.42 | $10.01 |
| 52 Week High | $3.73 | $24.33 |
Technical Indicators
Market Signals| Indicator | SES | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 33.90 | 47.88 |
| Support Level | $1.02 | $18.78 |
| Resistance Level | $1.22 | $20.09 |
| Average True Range (ATR) | 0.11 | 0.76 |
| MACD | -0.01 | 0.18 |
| Stochastic Oscillator | 9.85 | 74.82 |
Price Performance
Historical ComparisonAbout SES SES AI Corporation
SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.